Graham Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,281
| Closed | -$669K | – | 1296 |
|
|
2024
Q4 | $669K | Sell |
13,281
-8,223
| -38% | -$414K | 0.01% | 608 |
|
|
2024
Q3 | $995K | Buy |
21,504
+5,185
| +32% | +$240K | 0.02% | 435 |
|
|
2024
Q2 | $530K | Buy |
+16,319
| New | +$530K | 0.01% | 544 |
|
|
2024
Q1 | – | Sell |
-8,094
| Closed | -$263K | – | 1074 |
|
|
2023
Q4 | $263K | Buy |
+8,094
| New | +$263K | 0.01% | 739 |
|
|
2023
Q1 | – | Sell |
-11,945
| Closed | -$243K | – | 1083 |
|
|
2022
Q4 | $243K | Buy |
+11,945
| New | +$243K | 0.01% | 931 |
|
|
2022
Q2 | – | Sell |
-43,284
| Closed | -$974K | – | 1036 |
|
|
2022
Q1 | $974K | Buy |
+43,284
| New | +$974K | 0.03% | 306 |
|